Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Anaphylaxis; This is a spontaneous report from a contactable healthcare professional received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106060111378330-9YQCV. Safety Report Unique Identifier is GB-MHRA-ADR 25426658. A 32-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Jun2021 (lot number: EW3143) as single dose for COVID-19 immunisation. Medical history included peanut allergy. He has not had symptoms associated with COVID-19 and not enrolled in clinical trial. Concomitant medication included epinephrine (EPIPEN). The patient experienced anaphylaxis on 03Jun2021 with outcome of recovered on 03Jun2021. Case narrative: The patient reported feelings of anaphylaxis similar to when he had peanut allergy. Epipen discharged. He was monitored and taken to a hospital. He underwent lab tests and procedures which included COVID-19 virus test: no - negative COVID-19 test on an unknown date. Case was reported as non-serious by health authority. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166